86. Effect of Oral Fosfomycin Compared to the Intravenous Beta Lactam/Beta-Lactamase Inhibitor or Carbapenem in Step-down Treatment of Patients with Complicated Urinary Tract Infection due to Extended-Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriaceae: A Multicenter, Open-label, Randomized Controlled, Non-inferiority Trial
86. 口服磷霉素与静脉注射β-内酰胺类/β-内酰胺酶抑制剂或碳青霉烯类药物在由产超广谱β-内酰胺酶（ESBL）肠杆菌科细菌引起的复杂性尿路感染患者降阶治疗中的疗效比较：一项多中心、开放标签、随机对照、非劣效性试验
期刊:Canadian Medical Association Journal
影响因子:11.3
doi:10.1503/cmaj.220926
Amuah, Joseph Emmanuel; Molodianovitsh, Katy; Carbone, Sarah; Diestelkamp, Naomi; Guo, Yanling; Hogan, David B; Li, Mingyang; Maxwell, Colleen J; Muscedere, John; Rockwood, Kenneth; Sinha, Samir; Theou, Olga; Karmakar-Hore, Sunita; Díaz-Madriz, José P; Zavaleta-Monestel, Esteban; Chaverri-Fernández, José M; Arguedas-Chacón, Sebastián; Araya-Mena, Ariana; Rojas-Chinchilla, Carolina; Fernández-Aguilar, Guillermo; Muñoz-Gutierrez, Gabriel; Seo, Jun-won; Young Kim, Da; Yoon, Youngmin; Sang Lyu, Young; Sub Na, Yong; Sik Moon, Do; Ra Yun, Na; Seok Kim, Min; Kim, Jeong-Han; Woon Bae, Sang; Hur, Jian; Hyung Kim, Min; Soo Park, Yoon; Kim, Heejung; Lee, Hyungdon; Jang, Hee-Chang; Kim, Dong-Min
